logo
Plus   Neg
Share
Email

Stock Alert: Bicycle Therapeutics Jumps On Cancer Trials Update

Shares of Bicycle Therapeutics plc (BCYC) are surging more than 20% Thursday morning after the company announced its pipeline progress update for its early and mid-stage cancer trials.

Bicycle Therapeutics reported progress updates for its next-generation Bicycle Toxin Conjugates (BTCs) targeting oncological indications, as well as its novel, fully synthetic Bicycle tumor-targeted immune cell agonists (TICAs).

The company's lead candidate, BT1718, is progressing in the Phase IIa portion of the Cancer Research UK sponsored Phase I/IIa trial in patients with advanced solid tumors.

Phase I monotherapy portion of the study of BT5528 showed signs of anti-tumor activity, including one partial response and additional evidence of tumor reductions.

Pharmacokinetic profile of BT8009 is consistent with preclinical predictions based on early clinical data. Patient enrollment in phase I/IIa study of BT8009 in people with advanced solid tumors is ongoing.

preclinical data of mBT7480 has indicated a potential unique anti-tumor killing mechanism and phase I study to be started in the second half of this year.

"we have identified new TICAs targeting natural killer (NK) cells, which we are moving into lead optimization," said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics.

BCYC touched a new high of $25.51 this morning.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
South Korea's Hyundai Motor Co. announced its decision to suspend production at its Asan plant for two days starting on Monday due to a chip shortage amid the pandemic crisis, Reuters reported. The company is experiencing trouble in supply conditions for semiconductor parts for powertrain control units. The Asan factory manufactures 300,000 vehicles, including the Sonata and Grandeur sedans, each The U.S. Department of Health and Human Services is set to expand its Health Center COVID-19 Vaccine Program to include all HRSA-funded health centers. This will increase the total number of health centers that have been invited to join the program to 1,470 nationwide from the earlier 950. McDonald's Corp. is planning to hire 25,000 workers in its restaurants across Texas in April, reports said. In a three-day event from April 13 to 15, the fast-food chain is expected to hire for crew and management positions. During these hiring days, participating McDonald's restaurants in the state will be accepting applications and interviewing job seekers.
RELATED NEWS
Follow RTT